← Back to All Filings

Bio-Techne (TECH) Exec Sells $283K in Shares for Tax Purposes

Low SignificanceNovember 5, 2025 at 5:04:05 PM EST

BIO-TECHNE Corp

$TECH4CIK: 0000842023

Subscribe to track TECH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Bio-Techne (TECH) Exec Sells $283K in Shares for Tax Purposes

Company: BIO-TECHNE Corp (TECH) Form: 4 | Filed: 2025-11-05 Significance: Low

Insider: Geist William Title: PRESIDENT, PROTEIN SCIENCES | Relationship: Officer

Transaction: • Type: Tax Withholding (Sell-to-cover) • Shares: 4,520 • Price: $62.57 • Value: $282,816 • Owned After: 20,503

Key Insight: This was an automatic sale to cover tax liabilities from the vesting of 9,911 Restricted Stock Units (RSUs) and is not considered a discretionary trade reflecting insider sentiment.

Market Context: The transaction value represents a negligible 0.0029% of the company's $9.74 billion market capitalization.

Comprehensive Analysis

SEC Filing Analysis: BIO-TECHNE Corp (TECH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A company executive automatically sold shares to cover tax obligations arising from vested Restricted Stock Units (RSUs). This is a routine, non-discretionary transaction.
  • Market Impact: Neutral. The transaction is immaterial in size and does not signal a change in insider sentiment.

Company Information

FieldValue
CompanyBIO-TECHNE Corp
Ticker SymbolTECH
CIK0000842023
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameGeist William
CIK0001832210
Title/PositionPRESIDENT, PROTEIN SCIENCES
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-03
Transaction CodeF - Payment of tax liability by withholding securities
Security TypeCommon Stock
Shares Involved4,520
Price Per Share$62.57
Total Value$282,816.40
Shares Owned After20,503
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$282,816.40
% of Market Cap0.0029%
Shares Transacted4,520
% of Shares Outstanding0.0029%
Post-Transaction Ownership20,503 shares (0.0132% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction's value of approximately $283k is negligible compared to Bio-Techne's market capitalization of $9.74 billion.
  • Ownership Concentration: The insider's post-transaction ownership of 20,503 shares constitutes a very small fraction (0.0132%) of the total shares outstanding, indicating low ownership concentration from this individual.
  • Transaction Significance: The sale represents an insignificant percentage of both market cap and shares outstanding, falling far below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a non-discretionary "sell-to-cover" event, which is automated and required to satisfy tax obligations on equity compensation. It does not reflect a voluntary decision by the insider to reduce their stake in the company.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The market typically disregards 'F' coded transactions as they are not indicative of an insider's outlook.

Additional Context

Transaction Notes

  • This disposition (Code 'F') was executed to cover taxes related to the simultaneous vesting of 9,911 Restricted Stock Units, which were acquired by the insider (Code 'M'). The net result was an increase in the insider's total shareholdings.
Topics:#SECFiling#Form4#InsiderTrading#TECH#BioTechne#StockMarket#Finance#SellToCover

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.